PER 1.27% 8.0¢ percheron therapeutics limited

DMD is caused by the lack of Dystrophen which is the primary...

  1. 13,728 Posts.
    lightbulb Created with Sketch. 1461
    DMD is caused by the lack of Dystrophen which is the primary cause.
    Last weeks announcement which is yet to be recognised by the market. $$
    Atl1102 Re DMD fulfils the secondary target (Disease progression ) which is Inflation and Fibrosis..
    In combination with the present DMD drugs it does add to the efficacy to a point .( which Sarepta and others are looking for )
    By the end of this 1/4 we will have the results . Can Atl1102 generate Dystrophen
    Just a sniff of a positive result will send our Sp to 35c..( Game Changer)
    Keep the Faith:
    We Wait.


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.